An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia.
Conus
P
P
Nanzer
N
N
Baumann
P
P
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy*
D014150:Antipsychotic Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003024:Clozapine